State Street SPDR S&P Biotech ETF vs DENTSPLY SIRONA Inc — how do they compare? State Street SPDR S&P Biotech ETF trades at $154.5, while DENTSPLY SIRONA Inc trades at $13.56 (market cap $2.70B). The key difference: DENTSPLY SIRONA Inc pays a 5.04% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, DENTSPLY SIRONA Inc nearer its low. Which is the better fit depends on your goals.
| XBI | XRAY | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $164.28 | $16.85 |
52-Week Low | $85.16 | $9.64 |
Market Cap | — | $2.70B |
Enterprise Value | — | $4.84B |
Dividend Yield | — | 5.04% |
Trailing returns across standard periods
Latest headlines on both assets
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →